Advertisement

Hypopharyngeal Carcinoma

  • Benjamin H. Lok
  • Gaorav P. Gupta
  • Nadeem Riaz
  • Sean McBride
  • Nancy Y. Lee
Chapter
Part of the Medical Radiology book series (MEDRAD)

Abstract

The hypopharynx extends from the level of the hyoid bone to the inferiormost level of the cricoid cartilage. Anteriorly, the border is formed by the connection of the two pyriform sinuses at the postcricoid region and with the posterior extent defined by the posterior pharyngeal wall.

Keywords

Hyoid Bone Cricoid Cartilage Pyriform Sinus Posterior Pharyngeal Wall Hypopharyngeal Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Adams S, Baum RP, Stuckensen T et al (1998) Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25(9):1255–1260CrossRefGoogle Scholar
  2. Allen AM, Haddad RI, Tishler RB (2007) Retropharyngeal nodes in hypopharynx cancer on positron emission tomography. J Clin Oncol 25(5):599–601CrossRefGoogle Scholar
  3. Candela FC, Kothari K, Shah JP (1990) Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck 12(3):197–203CrossRefGoogle Scholar
  4. Castelijns JA, Gerritsen GJ, Kaiser MC et al (1988) Invasion of laryngeal cartilage by cancer: comparison of CT and MR imaging. Radiology 167(1):199–206CrossRefGoogle Scholar
  5. Di Martino E, Nowak B, Hassan HA et al (2000) Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 126(12):1457–1461CrossRefGoogle Scholar
  6. Gregoire V, Levendag P, Ang KK et al (2003) CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69(3):227–236CrossRefGoogle Scholar
  7. Ho CM, Lam KH, Wei WI et al (1993) Squamous cell carcinoma of the hypopharynx–analysis of treatment results. Head Neck 15(5):405–412CrossRefGoogle Scholar
  8. Lee NY, O’Meara W, Chan K et al (2007) Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 69(2):459–468CrossRefGoogle Scholar
  9. Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88(13):890–899CrossRefGoogle Scholar
  10. Prades JM, Lallemant B, Garrel R et al (2010) Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma. Acta Otolaryngol 130(1):150–155CrossRefGoogle Scholar
  11. Roychowdhury S, Loevner LA, Yousem DM et al (2000) MR imaging for predicting neoplastic invasion of the cervical esophagus. AJNR Am J Neuroradiol 21(9):1681–1687PubMedGoogle Scholar
  12. Rumboldt Z, Gordon L, Gordon L et al (2006) Imaging in head and neck cancer. Curr Treat Options Oncol 7(1):23–34CrossRefGoogle Scholar
  13. Schwartz DL, Ford E, Rajendran J et al (2005) FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 61(1):129–136CrossRefGoogle Scholar
  14. Wenig BL, Ziffra KL, Mafee MF et al (1995) MR imaging of squamous cell carcinoma of the larynx and hypopharynx. Otolaryngol Clin North Am 28(3):609–619PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Benjamin H. Lok
    • 1
  • Gaorav P. Gupta
    • 1
  • Nadeem Riaz
    • 1
  • Sean McBride
    • 1
  • Nancy Y. Lee
    • 1
  1. 1.Department of Radiation OncologyMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations